AJR InPractice
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patterson, S. A.
Right arrow Articles by Panicek, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patterson, S. A.
Right arrow Articles by Panicek, D. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.04.1030
AJR 2006; 187:307-312
© American Roentgen Ray Society


Original Research

MRI Evaluation of Small Hepatic Lesions in Women with Breast Cancer

Stacey A. Patterson1,2, Hanan I. Khalil1,3 and David M. Panicek1

1 Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021.
2 Present address: Department of Radiology, Mount Sinai Hospital of Queens, Queens, NY.
3 Present address: Department of Diagnostic Imaging, Brown University and Rhode Island Hospital, Providence, RI.

OBJECTIVE. The purpose of this study was to assess the utility of MRI in differentiating benign and malignant causes of hepatic lesions deemed too small to characterize on CT in women with breast cancer.

MATERIALS AND METHODS. A list of all women with breast cancer diagnosed between January 2000 and June 2003 was cross-referenced with radiologic and medical records to identify patients who had undergone MRI of the liver and who had had a hepatic lesion too small to characterize reported on previous CT performed after the diagnosis of breast cancer. The cause reported at MRI for each hepatic lesion too small to characterize seen on CT was recorded as benign, malignant, indeterminate, or no lesion seen on MRI. Subsequent relevant imaging examinations and medical records were reviewed.

RESULTS. Seventy-six (1.4%) of 5,440 women underwent MRI that included the liver. In 38 (50%) of the women a hepatic lesion too small to characterize was found on CT performed before MRI. The reported MRI diagnoses of hepatic lesions too small to characterize on CT included benign lesions (n = 22 women), lesions that remained indeterminate (n = 11 women), no lesion seen on MRI corresponding to the site of a lesion too small to characterize on CT (n = 8 women), and metastatic lesions (n = 2 women). Four women had more than one reported type of hepatic lesion. Subsequent findings of imaging, biopsy, or both performed on eight of 11 women with indeterminate lesions supported benign diagnoses in all eight women.

CONCLUSION. In women with newly diagnosed breast cancer and no definite liver metastasis on initial CT, immediate further evaluation of hepatic lesions too small to characterize with MRI offers only marginal benefit. In only approximately 5% of such women will lesions too small to characterize be shown on MRI to represent metastasis.

Keywords: breast cancer • CT • liver • MRI


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Roentgen Ray Society.